Procurement Summary
Country: Chile
Summary: Gsp Drug Supply Blinatumomab 35 Mcg Fus 2972026 Pomalidomide 4 Mg and Daratumumab 400 Mg Fus 4972026
Deadline: 04 Aug 2026
Posting Date: 17 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 145375227
Document Ref. No.: 1057055-54-LP26
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: CLP 130000000
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Products or services: Adalimumab, Vinblastine sulfate, Rituximab The objective of the Proposal is the SUPPLY OF MEDICINES BLINATUMOMAB 35 MCG (FUS 297/2026), POMALIDOMIDE 4 MG AND DARATUMUMAB 400 MG (FUS 497/2026) for the San Borja Clinical Hospital They will be lowered, requested in the technical specifications, in accordance with the Administrative and Technical Bases, Forms, clarifications and other documents that may be formulated during the course of the bidding. It will be understood that every supplier knows and irrevocably accepts the content of these Terms, by the sole fact of submitting offers in this bidding process.
Documents
Tender Notice